ESG investing: 3 UK shares I’d consider

Looking for shares to buy now from an ESG investing perspective, Christopher Ruane weighs the investment case for three UK stocks.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

ESG investing has become more popular as investors consider the environmental, social, and governance aspects of their holdings. The idea of ESG investing may sound appealing. But in practice there is no agreed standard of what constitutes an ESG share.

Here are three shares I think have at least some ESG credentials. I consider whether I would add them to my portfolio – but only one attracts me right now.

Access to medicine leader

Well-known pharma giant GlaxoSmithKline (LSE: GSK) is often prominent on lists ranking shares by their ESG credentials. That is because of the company’s focus on broadening access to medicine. The company came top out of 20 pharma companies assessed in this year’s Access to Medicine Index. GSK’s pipeline includes drugs targeting priority diseases prevalent in poorer countries.

That may give GSK some credibility when it comes to ESG investing. But I feel the investment case for the company is more mixed. The relative weakness of its pipeline has worried analysts in recent years. The dividend of 5.6% is attractive for a FTSE 100 stalwart. But the company has indicated that it may effectively reduce the dividend after the imminent spin-off of its consumer division.

Despite improving steadily since the start of March, the GSK share price is still down 14% over the past year. That reflects investor nervousness about the strategic listlessness of the company and its pipeline. The spin-off could help bring more focus – but that isn’t guaranteed. I’m tempted by the yield, but for now am sitting out GSK to see how the spin-off goes.

ESG investing in recycling

Shares in recycling service providers are an obvious candidate for ESG investing. Should I consider buying shares in Augean (LSE: AUG), which specialises in hazardous waste management? From landfill sites to decommissioned oil rigs, Augean is involved in activities including waste treatment and recycling.

There has been talk of a possible bid for Augean. The deadline for a firm bid expired last week but has now been extended to next month. The Augean share price is up 59% in the past year. Augean shares now trade on a price-to-earnings ratio of almost 20.

I think the company has growth potential due to its specialist expertise at a time of heightening environmental standards. But after an increase following the news of a possible bid, I wouldn’t add the shares to my portfolio right now. If a bid doesn’t materialise, the shares risk returning to where they were before bid speculation emerged.

Closed loop recycling

Another company involved in recycling is paper and packaging firm D S Smith (LSE: SMDS). From an ESG investing perspective, its closed loop approach to recycling offers environmental benefits.

I also like D S Smith’s business performance and strategic focus. Last year, revenue and post-tax profits both fell due to the pandemic. But demand for packaging has surged due to an increase in online shopping. With its well-established operations in Europe and North America, D S Smith should benefit from that. The demand surge also poses a risk, though, as material prices have moved sharply up – something the company flagged in its results last week. That could hurt profit margins.

But with its proven ability to profit from paper and packaging, I would consider buying D S Smith for my portfolio.

Christopher Ruane has no shares in any company mentioned. The Motley Fool UK has recommended DS Smith and GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£10,000 to invest in a SIPP? These stocks could send it surging in 2026

Dr James Fox details two stocks that he likes the look of for 2026. He believes they could help a…

Read more »

Investing Articles

With a 7% dividend yield, this could be one of the stock market’s best growth plays

Yes, that's right. This company has one of the largest dividends on the UK stock market, but Dr James Fox…

Read more »

Investing Articles

The key number that could signal a recovery for the Greggs share price in 2026

The Greggs share price has crashed in 2025, but is the company facing serious long-term challenges or are its issues…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Can the Rolls-Royce share price hit £16 in 2026? Here’s what the experts think

The Rolls-Royce share price has been unstoppable. Can AI data centres and higher defence spending keep the momentum going in…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

Up 150% in 5 years! What’s going on with the Lloyds share price?

The Lloyds share price has had a strong five years. Our writer sees reasons to think it could go even…

Read more »

Investing Articles

Where will Rolls-Royce shares go in 2026? Here’s what the experts say!

Rolls-Royce shares delivered a tremendous return for investors in 2025. Analysts expect next year to be positive, but slower.

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Up 40% this year, can the Vodafone share price keep going?

Vodafone shareholders have been rewarded this year with a dividend increase on top of share price growth. Our writer weighs…

Read more »

Buffett at the BRK AGM
Investing Articles

Here’s why I like Tesco shares, but won’t be buying any!

Drawing inspiration from famed investor Warren Buffett's approach, our writer explains why Tesco shares aren't on his shopping list.

Read more »